TRHC’s SinfoníaRx® to Provide Enhanced Clinical Opportunities to Community Pharmacies through Innovative Partnership with...
October 10 2019 - 8:00AM
Tabula Rasa HealthCare® (NASDAQ: TRHC), a
healthcare technology company advancing the field of medication
safety, will deepen its clinical intelligence footprint through
subsidiary company SinfoníaRx’s strategic partnership with Drake
University’s College of Pharmacy & Health Sciences. The
College, located in Des Moines, Iowa, is a nationally ranked
academic program known for leadership and innovation. The
partnership will provide community pharmacies additional revenue
opportunities through enhanced clinical and telehealth services.
“Our network of Clinical Intelligence Call Centers deliver
telehealth services that offer unprecedented patient engagement and
clinical empowerment,” said TRHC Chairman and CEO Calvin H.
Knowlton, PhD. “Certified providers at Drake University Clinical
Intelligence Call Center will further expand our ability to provide
community pharmacists with clinical escalation services and patient
engagement opportunities.”
TRHC’s Clinical Intelligence Call Center at Drake University
follows the company’s recent announcement of a new Comprehensive
Medication Review (CMR) offering for community pharmacists.
Further, across the country, community pharmacies are transforming
practices to offer enhanced, patient-centric clinical services.
Such is evident in Iowa’s “Flip the Pharmacy” initiative, a
Community Pharmacy Enhanced Services Networks (CPESN)
collaboration, awarded by The Community Pharmacy Foundation (CPF),
designed to promote the adoption of patient-focused processes and
business models.
“This partnership recognizes Drake’s focus on innovation and
entrepreneurial leadership as well as the quality of the pharmacy
education we provide,” said Renae Chesnut, dean of the college of
pharmacy and health sciences. “We are committed to providing our
students with opportunities to be involved in ground-breaking
patient care initiatives that utilize technology solutions like
those offered by TRHC.”
This partnership with Drake University marks both the
establishment of TRHC’s eighth nationwide Clinical Intelligence
Call Center and also represents TRHC’s direct alignment with
transformative pharmacy practices. TRHC’s comprehensive outreach
approach enables pharmacists and patients to collaborate on
ensuring medication safety.
About Tabula Rasa
HealthCare®
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific,
data-driven technology and organizational performance solutions
that enable healthcare organizations to optimize medication
regimens to improve patient outcomes, reduce hospitalizations,
lower healthcare costs and manage risk. TRHC provides solutions for
a range of payers, providers and other healthcare organizations.
For more information, visit TRHC.com.
TRHC’s SinfoníaRx® is a leading provider of Medication Therapy
Management (MTM) services. Through a comprehensive suite of
innovative healthcare solutions, SinfoníaRx provides direct support
to health plans, health systems, provider organizations, and
pharmacies. SinfoníaRx’s staff of nationally renowned clinical
pharmacists and interprofessional team work directly with
caregivers, patients, and providers to ensure the most effective
and safest medication therapy possible. For more information, visit
sinfoniarx.com.
TRHC’s PrescribeWellness® is a leading cloud-based patient
relationship management solutions company that facilitates
collaboration between more than 10,000 pharmacies, payers,
providers, pharmaceutical companies and their patients for better
health.
Visit tabularasahealthcare.com/our-solutions/technology-products/
About Drake University’s College of Pharmacy &
Health Sciences
The College of Pharmacy and Health Sciences provides an
intellectually stimulating learning environment with collaborative
learning among students, faculty, and staff. Graduates are
liberally educated professionals who are dedicated to serving their
clients, patients, profession, and community. The College
emphasizes excellence and leadership in education, service, and
scholarship.
Forward-Looking StatementsThis press release
includes forward-looking statements that we believe to be
reasonable as of today’s date, including statements regarding
Medication Risk Mitigation technology. Such statements are
identified by use of the words “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,”
“should,” and similar expressions. These forward-looking
statements are based on management’s expectations and assumptions
as of the date of this press release. Actual results might
differ materially from those explicit or implicit in the
forward-looking statements. Important factors that could cause
actual results to differ materially include: the need to innovate
and provide useful products and services; risks related to changing
healthcare and other applicable regulations; increasing
consolidation in the healthcare industry; managing our growth
effectively; our ability to adequately protect our intellectual
property; and the other risk factors set forth from time to time in
our filings with the SEC, including those factors discussed
under the caption “Risk Factors” in our most recent annual report
on Form 10-K, filed with the SEC on March 1, 2019, and in
subsequent reports filed with or furnished to the SEC, copies of
which are available free of charge within the Investor Relations
section of the TRHC website http://ir.trhc.com or upon request from
our Investor Relations Department. Any forward-looking statement
speaks only as of the date on which it was made. TRHC assumes no
obligation and does not intend to update these forward-looking
statements, except as required by law, to reflect events or
circumstances occurring after today’s date.
Media
ContactDianne Semingsondsemingson@trhc.comT: (215)
870-0829 |
Investors Bob
East or Asher Dewhurst Westwicke Partners
tabularasa@westwicke.com T: (443) 213-0500 |
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tabula Rasa HealthCare (NASDAQ:TRHC)
Historical Stock Chart
From Jul 2023 to Jul 2024